AKDITAL continues to demonstrate robust growth momentum in the first half of 2026, delivering strong financial performance alongside strategic network expansion. The Moroccan healthcare group reported consolidated revenue of 2.53 billion dirhams, representing a 21% increase compared to the same period in 2025, while net profit rose 20% to reach 252 million dirhams.

Network Expansion Drives Growth

During the first six months of 2026, AKDITAL expanded its national footprint with two significant openings: Anfa Prime Hospital in Casablanca and the International Clinic in Inezgane. The Casablanca facility represents the group's new "Prime" format, combining a multidisciplinary hospital, Onco Prime Hospital, and Cardio Prime Hospital under one roof. This innovative model integrates advanced medical expertise with cutting-edge technology, offering patients a personalized care pathway with enhanced focus on reception, comfort, and patient support.

The Inezgane facility strengthens AKDITAL's presence in the Souss-Massa region, bringing the total number of cities served to 25. With these four new facilities, the network now comprises 45 establishments with 4,864 beds—an increase of 359 beds since the beginning of the year.

Medical Innovation and International Expansion

AKDITAL's network development is accompanied by a consistent commitment to medical innovation, combining the expansion of robot-assisted surgery capabilities with pioneering procedures. Anfa Prime Hospital has already contributed to this effort by performing Morocco and Africa's first robotic sleeve gastrectomy, a surgical intervention for obesity treatment.

Internationally, AKDITAL has advanced preparations for its Saudi Arabian network by completing renovation work at AKDITAL Hospitals Riyadh Olaya in Riyadh and progressing with the acquisition of a majority stake in Al Bishri Hospital in Mecca, now renamed AKDITAL Makkah Al Mukarramah. The deployment extends to Jeddah, where the company signed a long-term lease agreement for the development, equipment, and management of Aladwani Hospital.

Strong Operating Performance

The consolidated revenue of 2,532 million MAD reflects a 21% increase compared to H1 2025. Both business segments contributed to this momentum, with oncology showing stronger growth and representing 36% of half-year revenue, up from 31% a year earlier. The multidisciplinary segment remains the group's primary division, accounting for 64% of revenue.

Activity growth translated into a 15% increase in admissions, reaching 590,842 during the semester. The distribution of patient admissions confirms the network's regional anchoring: facilities located outside the Casablanca-Rabat axis handled 71% of admissions and represent 68% of the group's bed capacity.

This geographic distribution facilitates access to specialized care, with 1,546 open-heart surgery admissions, 5,425 coronary dilations, 50,904 chemotherapy sessions, and 7,363 radiotherapy treatments during the semester, predominantly outside the Casablanca-Rabat axis. The network also recorded 18,580 births during the period.

Financial Performance and Investment

To support this expanding service offering, AKDITAL relies on 4,186 partner practitioners and 10,256 employees as of June 30, 2026—362 additional staff members since the beginning of the year.

Consolidated EBITDA reached 634 million MAD in H1 2026, up 19% compared to the same period in 2025. Consolidated net profit increased 20% to 252 million MAD, maintaining the net margin at 10%, while the group's share of net profit stood at 225 million MAD.

First-half 2026 consolidated investments totaled 875 million MAD. These funds support equipment for newly opened establishments in Morocco and maintenance of the existing network, as well as advancement of projects in the United Arab Emirates and Saudi Arabia, to which 477 million MAD was dedicated—approximately 55% of the total.

Consolidated net debt reached 4,858 million MAD as of June 30, 2026, up 14% compared to end-December 2025. The group notably completed a private placement bond issue of 300 million MAD in the second quarter, bringing total outstanding bonds to 1,500 million MAD. These resources are primarily intended for international development, with activities expected to gradually contribute to value creation from the second half of 2026.

Future Outlook

AKDITAL intends to continue developing its Moroccan network while supporting the launch of international operations. Domestically, upcoming openings and the ramp-up of recent establishments will support the expansion of healthcare services, with the ambition of operating 59 facilities in more than 29 cities by 2028, with capacity exceeding 6,000 beds. The deployment of the "Prime" format in major cities complements this program.

In Saudi Arabia, the commissioning of the Riyadh and Mecca facilities in September 2026 marks the beginning of the group's hospital network operations. Their ramp-up should gradually contribute to activity from the second half, while projects in Jeddah and Dubai continue to advance.

This development benefits from the partnership with Arab Invest, which acquired a 15% stake in AKDITAL International Company, based in Riyadh, to support the group's expansion, particularly in the Saudi market.

BOURSSOLE Newsroom

AKDITAL Reports 20% Net Profit Growth in H1 2026 Amid Network Expansion